Rivero-Menendez, O.; Soto-Debran, J.C.; Cuenca-Estrella, M.; Alastruey-Izquierdo, A.
In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies. J. Fungi 2021, 7, 232.
https://doi.org/10.3390/jof7030232
AMA Style
Rivero-Menendez O, Soto-Debran JC, Cuenca-Estrella M, Alastruey-Izquierdo A.
In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies. Journal of Fungi. 2021; 7(3):232.
https://doi.org/10.3390/jof7030232
Chicago/Turabian Style
Rivero-Menendez, Olga, Juan Carlos Soto-Debran, Manuel Cuenca-Estrella, and Ana Alastruey-Izquierdo.
2021. "In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies" Journal of Fungi 7, no. 3: 232.
https://doi.org/10.3390/jof7030232
APA Style
Rivero-Menendez, O., Soto-Debran, J. C., Cuenca-Estrella, M., & Alastruey-Izquierdo, A.
(2021). In Vitro Activity of Ibrexafungerp against a Collection of Clinical Isolates of Aspergillus, Including Cryptic Species and Cyp51A Mutants, Using EUCAST and CLSI Methodologies. Journal of Fungi, 7(3), 232.
https://doi.org/10.3390/jof7030232